Cyclooxygenase-2 expression and inhibition in atherothrombosis
about
Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cellsDeterminants of the interindividual variability in response to antiplatelet drugsLumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjectsAntithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actionsMonocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.Genes and abdominal aortic aneurysm.The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasiaExpression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signalingCOX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activationExposure to diesel exhaust upregulates COX-2 expression in ApoE knockout mice.Impact of maternal dexamethasone on coronary PGE(2) production and prostaglandin-dependent coronary reactivity.Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.Antiplatelet drug therapy: role of pharmacodynamic and genetic testing.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.High on-treatment platelet reactivity in peripheral endovascular procedures.The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II.Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study.Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events.Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity.Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers.Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity
P2860
Q24337408-8A38A7B4-20B2-486F-8036-F1A4157E96E5Q28187591-0BE3203A-A9B5-4D0E-BB02-801D9FBEB2A1Q28192026-2CAA6507-74C3-4D86-A9F2-B6CC352C5AC1Q28211940-20CA6933-8D55-4687-A63C-2593C4D5E0CCQ34055659-04F57DA6-C27D-4EC2-BDF8-3A13972C9AF6Q34636574-4BC523AA-6BF7-4BFD-AC00-D6EFE3983D1BQ34683905-845ED843-05E0-45D6-9A0F-0A43997DCA63Q34714208-C681936D-503E-4498-B957-765F74934C59Q35039893-BE684870-8E69-4B15-807B-F0F4D6CBAC26Q36229672-941A4F49-A782-4432-B571-D1EE9FF7CE3FQ36267799-F5C2DB6F-D668-48D7-BDFE-0D74AA70B2F6Q36309144-9FDB5F25-2EC6-400F-913B-068FC9536882Q37479004-958F43B9-BAEB-4BB1-95AF-2B954A25C64AQ37882712-2700EBCC-CC98-4967-A813-AEAC662FEA4AQ37893966-5F9EFB37-FBEC-45BA-BA12-5007B96301E2Q37995534-F03F864C-9125-4E7A-9AE2-4F03204B71ECQ38125134-8E437B4B-0213-4CCD-8B54-40AB154B7AD6Q38750444-214D93D3-4805-4E12-BB5F-1A9A731700ADQ42776854-7FB3F1FA-C6BE-4ED9-813F-6BF0E06A1150Q45285281-9B8CA9BA-3E73-406B-9097-3B34604FCB05Q48468577-93825A0F-1C08-4CA9-B201-DCA8DEF6FF3DQ53397053-1139E246-1E89-437D-A9E4-1F2B7A085175Q53798598-6F04E607-9E31-47A8-B9F4-BB1C42ABADDDQ57169425-5AEEFE66-464C-46AD-A296-56F70D588DA5
P2860
Cyclooxygenase-2 expression and inhibition in atherothrombosis
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@ast
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@en
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@nl
type
label
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@ast
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@en
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@nl
prefLabel
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@ast
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@en
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@nl
P1476
Cyclooxygenase-2 expression and inhibition in atherothrombosis
@en
P2093
Bianca Rocca
Carlo Patrono
P304
P356
10.1161/01.ATV.0000104005.92603.F2
P407
P577
2003-10-30T00:00:00Z